The prevalence of atopic triad in children with physician-confirmed atopic dermatitis - 24/04/13
![](/templates/common/images/mail.png)
![](/templates/common/images/entites/lowast.gif)
Abstract |
Background |
Atopic dermatitis (AD) is often associated with comorbidities such as allergic rhinitis and asthma.
Objective |
We sought to describe the frequency of these comorbidities in children with AD.
Methods |
We conducted a cross-sectional study of the first 2270 children with physician-confirmed AD enrolled in a large postmarketing cohort. All were queried for information on comorbidities using a questionnaire from the International Study of Asthma and Allergies in Childhood.
Results |
In all, 71.3% reported at least one additional form of atopy (symptoms of asthma or allergic rhinitis). A total of 33.3% reported only symptoms of asthma or allergic rhinitis whereas 38.0% reported symptoms of asthma and allergic rhinitis. By age 3 years, nearly 66% reported at least one additional form of atopy. A statistically significant trend toward poorer disease control was observed for those with additional atopic illnesses (P < .001).
Limitations |
This is a cross-sectional study.
Conclusion |
Individuals with AD exhibit a predisposition to additional atopic illnesses by age 3 years and in turn the presence of these illnesses correlates with poor disease control.
Le texte complet de cet article est disponible en PDF.Abbreviations used : AD, CI, FDA, ISAAC, OR, PEER
Plan
Supported by an unrestricted grant from Novartis to Trustees of the University of Pennsylvania to conduct the design, data management, and analysis aspects of the PEER study. |
|
Disclosure: Ms Leclerc is an employee of Novartis. Dr Margolis has a consulting relationship with Astellas Pharmaceuticals but not with Novartis. Drs Kapoor, Menon, and Bilker, and Mr Hoffstad, have no conflicts of interest to declare. |
Vol 58 - N° 1
P. 68-73 - janvier 2008 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?